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Supplementary Table 1. Ex vivo optogenetic stimulation of cholinergic neurons in the IPV-
GP. Table corresponds to Figure 3. Dose response curves summarizing the effects of altering 
light pulse power, frequency, and pulse width on heart rate. Summary of the heart rate response 
to stimulation before versus after atropine administration (t4 = 2.993, *P = 0.0402). mean ± s.e.m.; 
paired, two-tailed t-test. 
Power (mW)
(n  = 6)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
0 355.8 ± 37.7 355.1 ± 38.0 -0.2 ± 0.2
38 365.8 ± 34.1 307.2 ± 46.1 -16.0 ± 8.7
115 353.0 ± 35.4 228.3 ± 23.7 -31.8 ± 11.0
226 379.2 ± 35.6 200.3 ± 30.0 -45.9 ± 9.7
Frequency (Hz) 
(n  = 6)
1 353.5 ± 27.2 324.6 ± 13.2 -7.2 ± 3.3
5 357.8 ± 25.7 282.4 ± 18.3 -19.7 ± 7.1
10 347.9 ± 23.0 219.7 ± 21.0 -35.2 ± 8.0
20 351.2 ± 29.0 164.5 ± 42.9 -50.0 ± 14.9
Pulse width (ms)
(n  = 6)
1 355.6 ± 28.5 278.1 ± 23.8 -20.4 ± 8.0
2 362.1 ± 30.4 244.8 ± 25.4 -29.7 ± 10.3
10 356.6 ± 25.5 227.1 ± 21.6 -34.4 ± 8.2
Atropine
(n  = 5)
Pre 354.9 ± 35.3 224.2 ± 25.0 -33.5 ± 11.0*
Post 333.8 ± 37.7 333.0 ± 37.9 -0.3 ± 0.2
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Supplementary Table 2. In vivo optogenetic versus electrical stimulation of the vagus 
nerve. Table corresponds to Figure 4. Frequency response curves summarizing the effects of 
optogenetic versus electrical stimulation of the right vagus nerve on heart rate in the intact state, 
of the caudal end following RVNx and BVNx, and of the cranial end following RVNx (t4 = 3.576, 
*P = 0.0232 at 10 Hz; t4 = 5.229, **P = 0.0064 at 20 Hz) and BVNx (t4 = 8.588, **P = 0.0010 at 20 
Hz). mean ± s.e.m.; paired, two-tailed t-test. 
 
 
Frequency (Hz)
(n  = 8)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
1 560.7 ± 5.5 552.5 ± 5.9 -1.5 ± 0.2 594.1 ± 4.4 587.9 ± 4.5 -1.0 ± 0.2
5 561.6 ± 6.6 533.6 ± 5.3 -5.0 ± 0.3 593.4 ± 5.5 556.0 ± 8.7 -6.3 ± 0.8
10 552.0 ± 8.0 481.6 ± 8.7 -12.8 ± 0.4 590.7 ± 6.1 509.5 ± 6.3 -13.8 ± 0.6
20 558.3 ± 6.3 401.3 ± 13.0 -28.1 ± 2.2 591.6 ± 5.7 370.3 ± 32.0 -37.7 ± 5.0
Frequency (Hz)
(n  = 3)
1 545.8 ± 12.9 535.9 ± 13.1 -1.8 ± 0.6 564.2 ± 8.9 555.3 ± 8.0 -1.6 ± 0.5
5 550.9 ± 11.5 501.5 ± 9.2 -9.0 ± 1.0 567.7 ± 7.9 519.9 ± 13.3 -8.4 ± 1.9
10 562.2 ± 8.2 459.6 ± 19.5 -18.3 ± 2.5 568.2 ± 4.6 449.2 ± 33.0 -21.0 ± 5.7
20 549.3 ± 11.5 302.9 ± 46.0 -44.9 ± 8.1 564.2 ± 7.4 276.2 ± 47.6 -51.0 ± 8.5
Frequency (Hz)
(n  = 3)
1 530.0 ± 6.6 516.4 ± 5.9 -2.6 ± 0.4 558.9 ± 7.1 548.3 ± 10.6 -1.9 ± 0.7
5 534.0 ± 2.7 493.6 ± 5.7 -7.5 ± 1.5 549.8 ± 10.6 508.3 ± 28.5 -7.7 ± 3.4
10 560.6 ± 6.4 478.2 ± 16.7 -14.7 ± 2.3 546.9 ± 9.5 457.2 ± 33.8 -16.5 ± 5.1
20 545.6 ± 3.0 370.8 ± 44.5 -32.0 ± 8.3 551.5 ± 8.1 354.4 ± 69.3 -36.1 ± 11.5
Frequency (Hz)
(n  = 5)
1 533.4 ± 10.6 531.2 ± 10.7 -0.4 ± 0.1 569.5 ± 13.0 568.2 ± 13.5 -0.2 ± 0.2
5 539.3 ± 11.0 536.9 ± 10.5 -0.4 ± 0.2 569.6 ± 14.1 559.0 ± 19.5 -2.0 ± 1.3
10 556.6 ± 12.9 556.0 ± 12.7 -0.1 ± 0.1* 576.1 ± 10.8 539.5 ± 18.8 -6.5 ± 1.8*
20 550.1 ± 12.1 549.3 ± 11.7 -0.1 ± 0.1** 576.1 ± 11.2 519.5 ± 17.3 -9.9 ± 1.8**
Frequency (Hz)
(n  = 5)
1 518.5 ± 7.4 519.7 ± 8.5 0.2 ± 0.2 546.7 ± 7.5 546.9 ± 8.0 0.0 ± 0.2
5 526.1 ± 9.0 525.5 ± 9.4 -0.1 ± 0.1 545.2 ± 9.1 545.9 ± 8.9 0.1 ± 0.1
10 547.4 ± 5.9 545.5 ± 5.5 -0.3 ± 0.2 542.4 ± 8.5 539.7 ± 11.0 -0.5 ± 0.5
20 535.7 ± 6.9 534.9 ± 7.2 -0.2 ± 0.1** 545.6 ± 7.8 528.3 ± 8.7 -3.2 ± 0.4**
BVNx cranial RVNS
Intact RVNS
Optical Electrical
RVNx caudal RVNS
BVNx caudal RVNS
RVNx cranial RVNS
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Supplementary Table 3. In vivo optogenetic stimulation of noradrenergic neurons in the 
RSG. Table corresponds to Figure 6. Dose response curves summarizing the effects of altering 
frequency and pulse width on heart rate. Summary of the heart rate response to stimulation of the 
RSG versus RT2G (t6 = 5.435, **P = 0.0016). Summary of the heart rate response to RSG 
stimulation before versus after propranolol administration (t3 = 3.951, *P = 0.0289). mean ± s.e.m.; 
paired, two-tailed t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Frequency (Hz)
(n  = 7)
Baseline heart 
rate (bpm)
Stimulation 
heart rate (bpm) Δ Heart rate (%)
1 464.8 ± 22.6 471.7 ± 22.1 1.5 ± 0.4
2 458.6 ± 21.3 476.2 ± 22.6 3.8 ± 0.6
5 459.6 ± 22.1 486.5 ± 20.6 6.1 ± 1.1
10 455.7 ± 20.8 499.5 ± 20.4 9.9 ± 1.8
20 462.4 ± 20.2 499.8 ± 18.3 8.3 ± 1.1
Pulse width (ms)
(n  = 6)
1 469.5 ± 37.5 482.9 ± 33.8 3.4 ± 1.6
2 475.0 ± 38.8 492.0 ± 35.3 4.1 ± 1.8
5 475.3 ± 36.3 500.4 ± 33.0 5.9 ± 2.4
10 464.2 ± 32.0 499.0 ± 31.2 7.9 ± 2.2
RSG versus RT2G
(n  = 7)
RSG 461.7 ± 24.2 504.1 ± 23.1 9.5 ± 1.8**
RT2G 486.1 ± 39.4 487.6 ± 39.3 0.3 ± 0.2
Propranolol
(n  = 4)
Pre 471.5 ± 23.4 498.0 ± 26.0 5.6 ± 1.4*
Post 364.1 ± 20.1 364.7 ± 20.5 0.1 ± 0.1
 5 
 
Supplementary Figure 1. Whole-mount stained heart versus iDISCO-cleared heart. (a) A 
heart before (top) and after (bottom) whole-mount staining. (b) 3D confocal projection of the dorsal 
side of a heart (2000 µm z-stack) whole-mount stained with PGP9.5 (gray). Insets show a MIP 
image of the left ventricular wall (top right) and a 1000 µm-thick 3D projection of the left ventricular 
wall (bottom right). (c) A whole heart (top) was rendered transparent (bottom) using the iDISCO 
protocol. (d) 3D confocal projection of the dorsal side of an iDISCO-cleared heart (2000 µm z-
stack) stained with PGP9.5 (gray). Insets show a MIP image of the left ventricular wall (top right) 
and a 1000 µm-thick 3D projection of the left ventricular wall (bottom right). In contrast to whole-
mount stained hearts, nerve fibers could be visualized throughout the entire thickness of 
myocardium in iDISCO-cleared hearts. Scale bars are 2 mm (a, c), 1 mm (b (left), d (left)), and 
100 µm (b (right), d (right)). 
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Supplementary Figure 2. PACT clearing preserves fluorescence in virally and 
endogenously labeled hearts. (a) Example of a whole heart (top) that was rendered transparent 
(bottom) using the PACT protocol. (b) ssAAV-PHP.S:TRE-DIO-tdTomato-farnesylated (1 x 1012 
vg) and ssAAV-PHP.S:CAG-DIO-tTA (1 x 1011 vg) were systemically administered to a ChAT-
IRES-Cre mouse. Four weeks later, the whole heart was cleared using the PACT protocol. A 402 
µm-thick 3D projection of the left atrium showing cholinergic nerve fibers with native tdTomato 
fluorescence (gray). (c) tdTomato was expressed in noradrenergic neurons by crossing 
transgenic TH-IRES-Cre mice with Ai14 reporter mice containing a Cre-dependent tdTomato 
fluorescent protein allele (TH-tdTomato). The dorsal half of a heart from a TH-tdTomato mouse 
was cleared using the PACT protocol. A 1000 µm-thick 3D projection of the dorsal atrial wall 
showing noradrenergic neurons in cardiac ganglia with native tdTomato fluorescence (gray) (left). 
An 85 µm-thick 3D projection of the ventricle showing noradrenergic nerves and nerve terminals 
(right). Scale bar is 2 mm (a), 100 µm (b), 500 µm (c, left), and 50 µm (c, right). 
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Supplementary Figure 3. AAV-PHP.S preferentially transduces peripheral versus central 
cholinergic neurons. ssAAV-PHP.S:CAG-DIO-eYFP was systemically administered to ChAT-
IRES-Cre mice at 1 x 1012 vg per mouse. Three weeks later, eYFP fluorescence was assessed 
using an antibody for GFP. (a) Single-plane confocal images of the medulla (left) and dorsal motor 
nucleus of the vagus nerve (DMV) (right) whole-mount stained with ChAT (red) and GFP (green). 
White dashed ovals in the medulla show the location of the DMV. White dashed boxes in the DMV 
images indicate location of higher magnification images in white boxes. (b) Percentage of DMV 
neurons expressing GFP and ChAT over those expressing ChAT. (c) MIP images of the 
nodose/jugular ganglion complex whole-mount stained with PGP9.5 (red) and GFP (green). (d) 
MIP images of a cardiac ganglion from a heart whole-mount stained with PGP9.5 (red) and GFP 
(green). White dashed boxes indicate location of higher magnification images in white boxes. (e) 
Percentage of cardiac ganglion neurons expressing GFP and ChAT over those expressing GFP 
or ChAT, indicating specificity or efficiency of viral transduction, respectively. n = 4 mice (b) and 
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5 mice (e); mean ± s.e.m.. Scale bars are 500 µm (a (left)), 100 µm (a (right), c, d (right), and 1 
mm (d (left)). 
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Supplementary Figure 4. AAV-PHP.S for selective delivery of ChR2 to peripheral 
cholinergic neurons in the IPV-GP. ssAAV-PHP.S:CAG-DIO-ChR2-eYFP was systemically 
administered to ChAT-IRES-Cre mice at 1 x 1012 vg per mouse. Experiments were performed 5 
weeks post-injection. (a) MIP images of a cardiac ganglion from a heart whole-mount stained with 
PGP9.5 (red) and GFP (green). (b, c) Dose response curves summarizing the effects of altering 
stimulation frequency (b) and pulse width (c) on heart rate in Langendorff-perfused hearts. n = 3 
mice (b, c); mean ± s.e.m.. Scale bar is 100 µm (a). 
 
